Key Market Indicators
Korean antacid medicine sales are expected to reach $58 million by 2026. As of 2021, the market was worth $65 million, which is a 1.5% year-on-year decrease. Since 2013, the Korean market has grown by 2% year-on-year. Italy, Germany, and Chile are the next three largest markets.
